This webinar will provide:

• An understanding of Luminex xMAP‑based multiplex immunoassay solutions (RUO) that enable the simultaneous detection of multiple soluble immune stimulatory and inhibitory factors
• A more complete picture of cancer immunity in a blood sample, both on the transcript and protein level

Key learning objectives

• Outline immunoassay solutions to advance cancer research
• Discover cancer‑derived exosomes as novel class of biomarkers
• Provide insights into immuno‑monitoring approaches to characterize and understand key changes in the immune response to cancer
• Study mRNA cancer biomarkers using Invitrogen QuantiGene Plex assays for multiplex, high‑throughput gene expression analysis
• Study protein cancer biomarkers using Invitrogen ProcartaPlex assays for multiplex protein analysis

Speaker: